|
July 12
July 12, 2002
In This Issue:
Hormones and Alternatives, Red Wine and Prostates,
"Slip, Slap, Slop," Compassionate Use, Careers and Cancer,
Virus and Lymphoma, Large Study of Supplements
************************************************
NEWS HIGHLIGHTS
Combination-HRT Increases Breast Cancer Risk
Breast Cancer Survivors Use Alternatives to HRT
Hormones With Radiotherapy Improves Prostate Cancer Survival
Red Wine May Keep Prostate Cancer Cells in Check
Virus Linked To Type of Lymphoma
Expanded-Access to New Experimental Drug for "Compassionate Use"
************************************************
SLIP, SLAP, SLOP
American Cancer Society says Slip on a shirt, Slop on sunscreen, and Slap on a hat.
SKIN CANCER LINK LIST
This list includes about 100 sources of info about all kinds of skin cancer, including rare forms, with
links to photos as well as information for patients and professionals.
http://www.cancerindex.org/clinks2s.htm
Cancerpage.com's Skin Cancer Info
See especially our Treatment Guidelines by type of cancer and stage of illness.
http://cancerpage.matria.com/cancers/default.asp?channel=Skin_Cancer
************************************************
CAREERS AND CANCER
When facing cancer, employees and employers have rights and responsibilities related to the Americans
With Disabilities Act and the Family Medical Leave Act, and may need to know about EEOC's role in setting
parameters for "reasonable accommodations" for workers and managers. The Cosmetic Executive Women, a
professional organization for women in the beauty industry, created a web site covering many of these
legal issues as well as other practical concerns for people with cancer and their employers. Their
website also offers charts and checklists, tips on tracking medical documents, ways of being your
own advocate, and ideas for "Keeping Up Appearances."
http://www.cancerandcareers.org/
************************************************
LARGEST PROSTATE CANCER PREVENTION STUDY
One year ago, 400 medical facilities began recruiting men for the SELECT prostate cancer prevention
trial, the largest study of its kind. SELECT--The Selenium and Vitamin E Cancer Prevention Trial--
will continue recruiting until they reach 32,400 healthy men age 55 or older. The long-term study
hopes to determine the role of vitamin supplements in preventing prostate cancer. Since African-
Americans have a higher risk of prostate cancer than other men, study coordinators throughout the
U.S. and Canada hope to enroll at least 6,500 African-American men age 50 or older. Those who
participate in SELECT, may also be eligible for a study on preventing Alzheimer's Disease sponsored by the
National Institute on Aging focused on the same supplements. Selenium and vitamin E, both naturally
occurring nutrients, are antioxidants. They are thought to be capable of neutralizing toxins known
as "free radicals" that might otherwise damage the genetic material of cells and possibly lead to cancer.
These nutrients were chosen for study because of the results of two other large cancer prevention trials.
To join the study, see SELECT at http://www.crab.org/select/.
|